Merck reaffirms cardiovascular research commitment

"Merck & Co., Inc. has reaffirmed its commitment to discovering and developing novel treatments for a broad range of cardiovascular disorders, including atherosclerosis, hypertension, heart failure and metabolic syndrome. This year marks the 50th anniversary of the launch of the Company's first major medicine for cardiovascular disease" - Merck